Stephen A Hill's Net Worth

-$12.2 Thousand

Estimate Recalculated Jul 1, 2024 05:02PM EST

Who is Stephen A Hill?

Stephen A Hill does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Lipocine Inc., CATALYST BIOSCIENCES, INC., Cellectar Biosciences, Inc., and ARQULE INC.

SEC CIK

Stephen A Hill's CIK is 0001237404

Past Insider Trading and Trends

2007 was Stephen A Hill's most active year for acquiring shares with 10 total transactions. Stephen A Hill's most active month to acquire stocks was the month of September. 2007 was Stephen A Hill's most active year for disposing of shares, totalling 9 transactions. Stephen A Hill's most active month to dispose stocks was the month of September. 2016 saw Stephen A Hill paying a total of $100,425.70 for 58,780 shares, this is the most they've acquired in one year. In 2015 Stephen A Hill cashed out on 12,146 shares for a total of $81,621.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lipocine Inc. (LPCN) Snapshot price: $4.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+142.86%
7.5K
—
—
12.75K
Dec 16
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 27
Form 4
+31.25%
1.25K
$3.47
-$4,341.50
5.25K
Scheduled
Dec 29
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 16
Form 4
∞
4K
$4.95
$19,799.60
4K
Nov 13
Form 4
—
0
—
—
0
Jan 6
Form 3
—
0
—
—
0
No matching records found

CATALYST BIOSCIENCES, INC. (GYRE) Snapshot price: $11.71

President, CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.77%
-190.00
$10.07
-$1,913.30
1.19K
Sep 6
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Feb 20
Form 4
—
0
—
—
0
Jul 13
Form 4
—
0
—
—
0
Jun 9
Form 4
+31.82%
5K
$2.03
$10,150.00
20.71K
Dec 17
Form 4/A
—
0
—
—
0
Oct 22
Form 4
—
0
—
—
0
Oct 22
Form 4
-43.60%
-12.15K
$6.72
-$81,621.12
15.71K
Aug 28
Form 4
—
0
—
—
0
Aug 14
Form 4
+875.00%
175K
—
—
195K
Oct 17
Form 4
—
0
—
—
0
Jan 23
Form 4/A
∞
20K
$4.43
$88,577.00
20K
Mar 8 - Mar 11
Form 4
∞
20K
$4.43
$88,577.00
20K
Mar 8 - Mar 11
Form 4
—
0
—
—
0
Dec 3
Form 3
—
0
—
—
0
No matching records found

Cellectar Biosciences, Inc. (CLRB) Snapshot price: $3.505

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 24
Form 4
∞
18K
$1.08
$19,438.20
18K
Jun 4
Form 4
—
0
—
—
0
Jun 13
Form 4
-100.00%
-992.00
$2.21
-$2,192.41
0
Nov 29
Form 4
—
0
—
—
0
Oct 12
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jul 5
Form 4
+1,771.70%
9.39K
$2.12
$19,906.80
9.92K
Apr 20
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Feb 26
Form 4
∞
5.3K
$3.75
$19,875.00
5.3K
Aug 20
Form 3
—
0
—
—
0
No matching records found

ARQULE INC No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 4
Form 4
—
0
—
—
0
Jan 16
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 15
No matching records found